The number of joint replacement surgeries in 2022 outperformed historical averages1. To keep pace with these market developments we are now seeing a market fueled by new innovations - including the rise of robotics and the growth of tailored implant and technology designs. Our team is working closer than ever with orthopedic partners to bring these designs to life through our biomaterials expertise.
1. The Orthopedic Industry Annual Report 2023
30+ years of experience in developing orthopedic solutions.
Every second a patient receives a medical device containing a DSM Biomedical solution.
25 FDA Material Master Files available to support regulatory submissions.
Closing the patient ‘satisfaction gap’ is one of the greatest challenges faced by our partners. In fact, for knee replacement procedures alone, it’s estimated that 20% of patients are unsatisfied with the outcome.
Whether in joint reconstructions for the knee, hip, shoulder, or ankle, our partners need solutions that can help reduce the associated pain of implants and extend the implant life itself – thereby reducing the physical and financial cost of repeat surgeries. Today, our experts are working to address all of these challenges (and more).
High-strength biocompatible materials like our Ultra High Molecular Weight Polyethylene powders can also potentially extend the life of joint implants - limiting friction within the device thanks to their stronger crosslinking properties: great news for improved patient outcomes.
We are proud to offer you a portfolio of customizable, combinable, and sustainable biomaterials that is unrivaled in the medical industry.
At DSM Biomedical we’ve built a wealth of knowledge in joint reconstruction.
Looking for more information on how our orthopedic biomaterials can help you tackle unmet needs?
Discover how we can partner with you to create new solutions for joint reconstruction that can improve patient care.
Our orthopedic experts are here to help.